A Medtronic (NYSE:MDT) official said today on LinkedIn that the company won CE mark for its Crescent RA jugular dual lumen ...

The US is in the throes an unusually intense and severe flu season, with hospitalization rates topping the levels seen with ...

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients.

Public health officials are looking into reports of a small potential uptick in neurologic complications of influenza in children -- particularly a rapidly progressing and dangerous condition called ...